ASMB three-lens brief
Evidence-based stock research on ASMB. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +4.78% yesterday. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Moved +4.78% yesterday.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Analyst mean target $51.20 — 129% above current (5 analysts).
- Negative free cash flow last quarterly (-$27.87M).
- Reported earnings on 2026-11-09.
ASMB closed at $22.37 (+4.78%) as of 2026-11-12. Market cap: $455.47M. P/E (trailing) 21.5. Price is below the 50-day MA and below the 200-day MA. Positives: moved +4.78% yesterday.; analyst mean target $51.20 — 129% above current (5 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; negative free cash flow last quarterly (-$27.87M).. Last quarter: Revenue $8.21M, net income -$9.08M, free cash flow -$27.87M.
Why three lenses on ASMB, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ASMB across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ASMB" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ASMB brief"></iframe>